Literature DB >> 21300073

Mathematical model of a three-stage innate immune response to a pneumococcal lung infection.

Amber M Smith1, Jonathan A McCullers, Frederick R Adler.   

Abstract

Pneumococcal pneumonia is a leading cause of death and a major source of human morbidity. The initial immune response plays a central role in determining the course and outcome of pneumococcal disease. We combine bacterial titer measurements from mice infected with Streptococcus pneumoniae with mathematical modeling to investigate the coordination of immune responses and the effects of initial inoculum on outcome. To evaluate the contributions of individual components, we systematically build a mathematical model from three subsystems that describe the succession of defensive cells in the lung: resident alveolar macrophages, neutrophils and monocyte-derived macrophages. The alveolar macrophage response, which can be modeled by a single differential equation, can by itself rapidly clear small initial numbers of pneumococci. Extending the model to include the neutrophil response required additional equations for recruitment cytokines and host cell status and damage. With these dynamics, two outcomes can be predicted: bacterial clearance or sustained bacterial growth. Finally, a model including monocyte-derived macrophage recruitment by neutrophils suggests that sustained bacterial growth is possible even in their presence. Our model quantifies the contributions of cytotoxicity and immune-mediated damage in pneumococcal pathogenesis. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21300073      PMCID: PMC3066295          DOI: 10.1016/j.jtbi.2011.01.052

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  62 in total

1.  Allometric relationships of cell numbers and size in the mammalian lung.

Authors:  K C Stone; R R Mercer; P Gehr; B Stockstill; J D Crapo
Journal:  Am J Respir Cell Mol Biol       Date:  1992-02       Impact factor: 6.914

2.  Characterization of murine lung interstitial macrophages in comparison with alveolar macrophages in vitro.

Authors:  G Franke-Ullmann; C Pförtner; P Walter; C Steinmüller; M L Lohmann-Matthes; L Kobzik
Journal:  J Immunol       Date:  1996-10-01       Impact factor: 5.422

3.  Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages.

Authors:  M J Thomassen; L T Buhrow; M J Connors; F T Kaneko; S C Erzurum; M S Kavuru
Journal:  Am J Respir Cell Mol Biol       Date:  1997-09       Impact factor: 6.914

4.  Some aspects of the pneumococcal carrier state.

Authors:  R Austrian
Journal:  J Antimicrob Chemother       Date:  1986-07       Impact factor: 5.790

5.  Interleukin-10 impairs host defense in murine pneumococcal pneumonia.

Authors:  T van der Poll; A Marchant; C V Keogh; M Goldman; S F Lowry
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

6.  A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice.

Authors:  K A Benton; M P Everson; D E Briles
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

Review 7.  Cytokine production by epithelial cells.

Authors:  A W Stadnyk
Journal:  FASEB J       Date:  1994-10       Impact factor: 5.191

Review 8.  The production of cytokines by polymorphonuclear neutrophils.

Authors:  M A Cassatella
Journal:  Immunol Today       Date:  1995-01

Review 9.  Early responses to infection: chemokines as mediators of inflammation.

Authors:  N W Schluger; W N Rom
Journal:  Curr Opin Immunol       Date:  1997-08       Impact factor: 7.486

10.  Selectins and neutrophil traffic: margination and Streptococcus pneumoniae-induced emigration in murine lungs.

Authors:  J P Mizgerd; B B Meek; G J Kutkoski; D C Bullard; A L Beaudet; C M Doerschuk
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more
  41 in total

Review 1.  Secondary bacterial infections in influenza virus infection pathogenesis.

Authors:  Amber M Smith; Jonathan A McCullers
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

2.  Time and dose-dependent risk of pneumococcal pneumonia following influenza: a model for within-host interaction between influenza and Streptococcus pneumoniae.

Authors:  Sourya Shrestha; Betsy Foxman; Suzanne Dawid; Allison E Aiello; Brian M Davis; Joshua Berus; Pejman Rohani
Journal:  J R Soc Interface       Date:  2013-07-03       Impact factor: 4.118

3.  sEH promotes macrophage phagocytosis and lung clearance of Streptococcus pneumoniae.

Authors:  Hong Li; J Alyce Bradbury; Matthew L Edin; Joan P Graves; Artiom Gruzdev; Jennifer Cheng; Samantha L Hoopes; Laura M DeGraff; Michael B Fessler; Stavros Garantziotis; Shepherd H Schurman; Darryl C Zeldin
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

4.  A mathematical model of intrahost pneumococcal pneumonia infection dynamics in murine strains.

Authors:  Ericka Mochan; David Swigon; G Bard Ermentrout; Sarah Lukens; Gilles Clermont
Journal:  J Theor Biol       Date:  2014-03-02       Impact factor: 2.691

5.  L-plastin is essential for alveolar macrophage production and control of pulmonary pneumococcal infection.

Authors:  Lauren E Deady; Elizabeth M Todd; Chris G Davis; Julie Y Zhou; Nermina Topcagic; Brian T Edelson; Thomas W Ferkol; Megan A Cooper; Jared T Muenzer; Sharon Celeste Morley
Journal:  Infect Immun       Date:  2014-03-04       Impact factor: 3.441

Review 6.  Current concepts in host-microbe interaction leading to pneumococcal pneumonia.

Authors:  Joshua Vernatter; Liise-anne Pirofski
Journal:  Curr Opin Infect Dis       Date:  2013-06       Impact factor: 4.915

7.  E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae.

Authors:  David M Aronoff; Ingrid L Bergin; Casey Lewis; Deepti Goel; Edmund O'Brien; Marc Peters-Golden; Peter Mancuso
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-04-02       Impact factor: 3.072

8.  A model for the optimization of anti-inflammatory treatment with chemerin.

Authors:  Simao Laranjeira; Daniel Regan-Komito; Asif J Iqbal; David R Greaves; Stephen J Payne; Piotr Orlowski
Journal:  Interface Focus       Date:  2017-12-15       Impact factor: 3.906

9.  Importance of bacterial replication and alveolar macrophage-independent clearance mechanisms during early lung infection with Streptococcus pneumoniae.

Authors:  Emilie Camberlein; Jonathan M Cohen; Ricardo José; Catherine J Hyams; Robin Callard; Suneeta Chimalapati; Jose Yuste; Lindsey A Edwards; Helina Marshall; Nico van Rooijen; Mahdad Noursadeghi; Jeremy S Brown
Journal:  Infect Immun       Date:  2015-01-12       Impact factor: 3.441

10.  Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae.

Authors:  Amber M Smith; Frederick R Adler; Ruy M Ribeiro; Ryan N Gutenkunst; Julie L McAuley; Jonathan A McCullers; Alan S Perelson
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.